Halozyme Therapeutics shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $445k | 39M | 0.01 |
| 2025-06-30 | $61M | 61M | 1.00 |
| 2025-03-31 | $37M | 35M | 1.06 |
| 2024-12-31 | $34M | 36M | 0.96 |
| 2024-09-30 | $36M | 36M | 1.01 |
| 2024-06-30 | $43M | 45M | 0.96 |
| 2024-03-31 | $39M | 44M | 0.89 |
| 2023-12-31 | $32M | 37M | 0.87 |
| 2023-09-30 | $15M | 18M | 0.85 |
| 2023-06-30 | $2.5M | 3.0M | 0.84 |
| 2023-03-31 | $0 | 0 | 0.00 |
| 2022-12-31 | $0 | 0 | 0.00 |
| 2022-09-30 | $0 | 0 | 0.00 |